openPR Logo
Press release

Dilyx Appoints Distributor in Japan

11-16-2011 10:10 AM CET | Health & Medicine

Press release from: Dilyx Biotechnologies

Dilyx Biotechnologies, LLC is pleased to announce that is has signed an agreement with Funakoshi Co. Ltd. of Japan, to distribute Dilyx’ protein solubility products in that region.

Dave Dilyx, Technical Advisor of Dilyx said: “I am delighted to have secured such an outstanding organization as distributor of our protein solubility products in Japan. Funakoshi has an excellent reputation amongst life scientists in Japan and we have been very impressed by their sales, technology and service capability. This agreement enhances our access to customers, and will significantly reinforce our presence in the Asia region”.
Commenting on the agreement, Dr. Ryoya Funakoshi, President and CEO of Funakoshi Co. Ltd. added: “Dilyx’ innovative product line will be an excellent addition to our current life science portfolio and I am very pleased to have Dilyx Biotechnologies as a partner”.

The fast market acceptance of the OptiSol Protein Solubility Kit in Europe and USA together with the favorable reception of the recently launched OptiResc Protein Aggregate Solubilization Kit has driven the implementation of our strategy for product distribution in Japan.

Dilyx Biotechnologies, LLC is a privately held, Seattle, WA based biotechnology company launching innovative products that help life science researchers to better understand and improve protein sample behavior.

Dave Dilyx, Technical Advisor
Dilyx Biotechnologies, LLC
815 1st Ave
Seattle
WA 98104, USA
dave@dilyx.com

Phone: 425-205-0588
Fax: 202-207-0398
Web: www.dilyx.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dilyx Appoints Distributor in Japan here

News-ID: 200664 • Views:

More Releases from Dilyx Biotechnologies

Dilyx Launches Kit for Improved Protein Solubility
Seattle, WA, 17 November, 2010 - Dilyx Biotechnologies, LLC announces the launch of the OptiSol Protein Solubility Screening Kit, allowing research scientists to aggregation-proof their protein samples. The resulting data saves effort and money because it informs life science researchers on how to best treat specific samples for storage or analysis. Find more information at http://www.dilyx.com/protein-solubilization-kit/ Since protein aggregation is the number one cause of inadvertent protein sample loss, Dilyx’

More Releases for Funakoshi

Live Cell Imaging Dye Market to Witness Steady Growth in 2024: Market Size and S …
Los Angeles, USA: QY Research has recently unveiled a comprehensive report titled, "Global Live Cell Imaging Dye Market Report: Insights, Forecast to 2030." This detailed analysis examines the multiple elements shaping the future of the global Live Cell Imaging Dye market. The Live Cell Imaging Dye report serves as an invaluable resource for industry players, providing precise and extensive research insights necessary for strategic decision-making. The analysts have conducted an in-depth
Dyed Microspheres Market 2023: Competitive Landscape, Key Players, Future Develo …
Dyed Microspheres Market 2023 Forecast: Unveiling Opportunities and Growth Dyed Microspheres market report presents an overview of the market on the basis of key parameters such as market size, revenue, sales analysis and key drivers. The market size of global Dyed Microspheres market is anticipated to grow at large scale over the forecast period (2023-2029). The main purpose of the study report is to give users an extensive viewpoint of the
Artificial Cerebrospinal Fluid (ACSF) Market Outlook by Analysing the Performanc …
The latest release from WMR titled Artificial Cerebrospinal Fluid (ACSF) Market Research Report 2022-2029 contains all relevant information and Growth Factors. 𝐏𝐫𝐨𝐯𝐢𝐝𝐢𝐧𝐠 𝐢𝐭𝐬 𝐜𝐥𝐢𝐞𝐧𝐭𝐬 𝐰𝐢𝐭𝐡 𝐚𝐜𝐜𝐮𝐫𝐚𝐭𝐞 𝐝𝐚𝐭𝐚, 𝐢𝐭 𝐩𝐫𝐨𝐯𝐢𝐝𝐞𝐬 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐨𝐮𝐭𝐥𝐨𝐨𝐤 𝐚𝐧𝐝 𝐡𝐞𝐥𝐩𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐦𝐚𝐤𝐢𝐧𝐠 𝐨𝐟 𝐜𝐫𝐮𝐜𝐢𝐚𝐥 𝐝𝐞𝐜𝐢𝐬𝐢𝐨𝐧𝐬. The market is described in general terms, along with its definition, uses, advancements, and production technology. This market research study on Artificial Cerebrospinal Fluid (ACSF) keeps tabs on all emerging
Artificial Cerebrospinal Fluid (ACSF) Market Key Players to Witness Huge Revenue …
Artificial Cerebrospinal Fluid (ACSF) Market report 2022 gives a brief well-informed report so that the purchaser or readers will get help from it for investment in Artificial Cerebrospinal Fluid (ACSF) Industry. The report is properly deliberate and gathered by Market professionals and will shed light on the key information that requires from the consumers like market share, size, top key players, and other important data. The Artificial Cerebrospinal Fluid (ACSF)
Artificial Cerebrospinal Fluid Market Global Top Countries Analysis And Opportu …
Worldwide Market Reports released a report on "Global Artificial Cerebrospinal Fluid Market Growth 2022", which covers segment analysis, regional and national level analysis along key players operating in the market. In addition to this, the report also focused on the size, share, trends, and forecast of the market. The report also includes impact analysis along with industry size and revenue. The research report also focused on the drivers, constraints, and
GALNT1 Antibody Market Next Big Thing | Major Market Players are Funakoshi, Cite …
According to a new examination on the GALNT1 Antibody market, a clear state of affairs of the market environment is available, spanning the modern-day and future status of the market. The scope and chance of being profitable, in addition to the producer profile, production details, and intake tendencies, have all been thoroughly researched within the forecast period. They have a look at presents facts on rising traits and market dynamics